Tarsus Pharmaceuticals Inc.

04/23/2024 | Press release | Distributed by Public on 04/23/2024 06:40

Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon